Article
Oncology
Bertha Alejandra Martinez-Cannon, Karen Garcia-Ronquillo, Monica M. Rivera-Franco, Eucario Leon-Rodriguez
Summary: This study evaluated the association between circulating neutrophil extracellular traps (NETs) and clinicopathological characteristics and outcomes in early breast cancer. The results showed no statistically significant associations between circulating NETs levels and clinicopathological characteristics, recurrence, or site of recurrence.
FRONTIERS IN ONCOLOGY
(2023)
Editorial Material
Oncology
Phei Er Saw, Jianing Chen, Erwei Song
Summary: Neutrophil extracellular traps (NETs) are involved in both infection control and tumor metastasis. The study by Mousset et al. published in Cancer Cell reveals that chemotherapy-induced inflammation promotes NETosis in malignant tumors, leading to chemoresistance. This finding highlights the potential of targeting inflammatory NETs for cancer treatment.
Article
Biochemistry & Molecular Biology
Remo Poto, Leonardo Cristinziano, Luca Modestino, Amato de Paulis, Gianni Marone, Stefania Loffredo, Maria Rosaria Galdiero, Gilda Varricchi
Summary: Human neutrophils play a significant role in the host response against pathogens, and recent research has revealed their functional plasticity and involvement in cancer and angiogenesis. Neutrophils release angiogenic factors and form NETs, which promote tumor growth and metastasis through various mechanisms. Understanding the functions of NETs in cancer and angiogenesis could be important for early diagnosis, prevention, and treatment of tumors.
Article
Oncology
Muhammad H. Shahzad, Lixuan Feng, Xin Su, Ariane Brassard, Iqraa Dhoparee-Doomah, Lorenzo E. Ferri, Jonathan D. Spicer, Jonathan J. Cools-Lartigue
Summary: Neutrophils play a role in cancer by releasing neutrophil extracellular traps (NETs) that interact with cancer cells, driving resistance to therapy. NETs are involved in various mechanisms of therapy resistance, including T-cell exhaustion, drug detoxification, angiogenesis, and extracellular matrix remodeling. Therefore, understanding and targeting NETs is crucial for effective cancer treatment.
Review
Oncology
Christof Kaltenmeier, Richard L. Simmons, Samer Tohme, Hamza O. Yazdani
Summary: Neutrophil Extracellular Traps (NETs) play a crucial role in cancer progression, particularly in promoting premetastatic niche formation, interacting with circulating cancer cells, and facilitating epithelial to mesenchymal transition during cancer metastasis. Targeting NETs may offer potential treatment options to impede tumor progression.
Article
Engineering, Biomedical
Ying Zhang, Cong Wang, Weishuo Li, Wei Tian, Chunming Tang, Lingjing Xue, Ziming Lin, Guilai Liu, Dongfei Liu, Ying Zhou, Qianqian Wang, Xu Wang, Lutz Birnbaumer, Yong Yang, Xianjing Li, Caoyun Ju, Can Zhang
Summary: The study proposes a general CTC intervention strategy based on neutrophil cyto-pharmaceuticals to suppress CTC colonization and metastasis formation, offering a new perspective for understanding the mechanism of CTC colonization and suggesting targeted intervention as a meaningful treatment for tumor metastasis.
ADVANCED HEALTHCARE MATERIALS
(2022)
Article
Multidisciplinary Sciences
Hannes A. Baukmann, Justin L. Cope, Colin Bannard, Alexander R. E. C. Schwinges, Margaretha R. J. Lamparter, Sarah Groves, Charles N. J. Ravarani, Borko Amulic, Joern E. Klinger, Marco F. Schmidt
Summary: Despite the availability of vaccines to prevent SARS-CoV-2 infection, treating critically ill COVID-19 patients remains crucial. This study presents an alternative method for identifying drug repurposing targets by screening disease-causing traits, leading to the discovery of potential treatment targets for critical illness.
Review
Oncology
Jingxuan Xia, Zhiyuan Zhang, Yijin Huang, Yufei Wang, Guangwei Liu
Summary: This article summarizes the formation process of neutrophil extracellular traps (NETs), their regulatory role in tumor development, and treatment methods based on NETs. NETs have the ability to awaken latent tumor cells and promote their proliferation and development, while also inhibiting tumor growth. These advancements provide a theoretical basis for the development of NET-targeted drugs.
INTERNATIONAL JOURNAL OF CANCER
(2023)
Article
Chemistry, Multidisciplinary
Zhengze Lu, Yang Long, Jiaxin Li, Kebai Ren, Wei Zhao, Xuhui Wang, Chunyu Xia, Yashi Wang, Man Li, Zhirong Zhang, Qin He
Summary: The developed LA/DOX NP can inhibit inflammatory cell recruitment in the liver and lungs through multiple mechanisms, block NF-kappa B and STAT3 signaling pathways, thereby shutting down inflammatory feed-forward loops, providing a new therapeutic strategy for breast cancer and its metastasis.
JOURNAL OF CONTROLLED RELEASE
(2021)
Review
Oncology
Urszula Demkow
Summary: This review focuses on the pro-tumorigenic action of neutrophil extracellular traps (NETs), which are found in various human and animal tumors. NETs play a crucial role in tumor development by awakening dormant cancer cells, regulating the tumor microenvironment, and enhancing tumor aggressiveness. Understanding the crosstalk between cancer and NETs can lead to novel therapeutic interventions to block cancer evasion mechanisms and prevent metastatic spread.
Article
Chemistry, Multidisciplinary
Zeyu Jiang, Xiangwu Chen, Yang Lin, Qian Li, Xinxin Nie, Guixiang Xu, Cancan Yu, Xinke Zhang, Yuxia Luan
Summary: A B7-H4 checkpoint-based photodynamic nanodrug combined with NETs-degrading enzyme DNase I is designed for treating immune-cold triple-negative breast cancer (TNBC). This synergistic approach enables cascade amplification of B7-H4 target-based outcomes and disrupts NETs-mediated metastasis, providing a potent strategy to reinvigorate the antitumor immune response and enhance the efficacy of TNBC immunotherapy.
ADVANCED FUNCTIONAL MATERIALS
(2023)
Review
Oncology
Yue Chen, Haoyue Hu, Songtao Tan, Qionglan Dong, Xue Fan, Yi Wang, Huan Zhang, Jun He
Summary: This review discusses the role of neutrophil extracellular traps (NETs) in cancer. Research has found that NETs are closely associated with cancer progression, metastasis, and cancer-associated thrombosis. The article summarizes the current understanding of NET formation and explores the potential applications of NETs in cancer therapy.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY
(2022)
Editorial Material
Medicine, Research & Experimental
Erin B. Taylor
Summary: This article discusses the importance of dysregulation of neutrophil extracellular trap formation in viral infections and explores treatment methods targeting NET formation.
Article
Biochemistry & Molecular Biology
Jiajing Zhao, Xiaojun Xie
Summary: This study retrieved transcriptome data and clinical information of BRCA patients from TCGA and GEO databases, and generated an expression matrix of NETs related genes. By clustering and exploring signaling pathways, it was found that high risk group is associated with poor immunotherapy response and adverse clinical outcomes in breast cancer patients.
FRONTIERS IN MOLECULAR BIOSCIENCES
(2023)
Review
Biochemistry & Molecular Biology
Marina Stoimenou, Georgios Tzoros, Panagiotis Skendros, Akrivi Chrysanthopoulou
Summary: Several studies suggest that NETs may play a role in inflammatory and thrombotic disorders, thus serving as potential therapeutic or diagnostic tools. This article compares commonly used techniques for assessing NET formation and discusses the challenges and advantages in evaluating NETs. The review provides insights into the molecular analysis of NETs in translational medicine today.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Immunology
Jun Cui, Cheng Chen, Xiao Zhou, Wenju Shan, Yuhong Jian, Panpan Li, Yang Sun, Wei Yi
Summary: Bone marrow mesenchymal stem cells (BMSCs) are a promising therapy for sepsis, but metabolic syndromes threaten their effectiveness. This study investigated the potential of small extracellular vesicles from high-fat diet BMSCs in sepsis-induced liver-heart axis injury.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2024)
Article
Immunology
Binbin Zhu, Angyang Cao, Chunqu Chen, Weijian Zhou, Wenjun Luo, Yu Gui, Qinwen Wang, Zhipeng Xu, Jianhua Wang
Summary: GM6001 alleviates postoperative cognitive deficits and neuroinflammation, preserves blood-brain barrier integrity, and rescues aquaporin-4 mislocalization. MMP-9 inhibition plays a dual role in cognitive protection through direct anti-neuroinflammatory effects and regulation of aquaporin-4 membrane distribution.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2024)
Article
Immunology
Anika Sood, Valencia Fernandes, Kumari Preeti, Shruti Rajan, Dharmendra Kumar Khatri, Shashi Bala Singh
Summary: S1PR2 inhibitor improves cognitive function and skews microglia toward anti-inflammatory phenotype in type 2 diabetic mice, promising to be a potential therapy for neuroinflammation.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2024)
Article
Immunology
Haochun Guo, Ran Yu, Haijun Zhang, Wanpeng Wang
Summary: Radiation therapy is an effective treatment for thoracic malignancies, but it can cause radiation-induced lung injury (RILI), including radiation pneumonitis (RP) and radiation pulmonary fibrosis (RPF). The damage to normal lung cells during radiation treatment leads to a pulmonary inflammatory response, resulting in RP and RPF.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2024)
Article
Immunology
Guanghui Wang, Haotian Zheng, Yunzhi Xiang, Yadong Wang, Kai Wang, Xiaoyang Ren, Jiajun Du
Summary: This study identified a T-cell synthetic driver-associated prognostic model that accurately predicted prognosis and effectiveness of immunotherapy in LUAD patients. It also highlighted the role of LDHA in promoting tumor cell proliferation, invasion, and resistance to treatment, as well as its involvement in immune escape within the tumor microenvironment. These findings provide a promising new therapeutic strategy for LUAD.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2024)
Article
Immunology
Bowen Wei, Aihua Wang, Wei Liu, Qingyun Yue, Yihua Fan, Bin Xue, Siwei Wang
Summary: This study systematically analyzed the association between pSS and cuproptosis, established a predictive model based on 5 genes, explored the pathogenic mechanisms and novel therapeutic strategies for pSS, and identified EED, CBL, and NFU1 as potential targets for treatment.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2024)
Article
Immunology
Nusrit Iqbal Andrabi, Aminur R. Sarkar, Syed Assim Haq, Diljeet Kumar, Dilpreet Kour, Diksha Saroch, Sanket Kumar Shukla, Ajay Kumar, Asha Bhagat, Asif Ali, Gurleen Kour, Zabeer Ahmed
Summary: Koenimbine and its novel semi-synthetic derivative 1G demonstrate significant anti-inflammatory effects by downregulating the nuclear factor kappa-B (NF-kappa B) signaling pathway.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2024)
Article
Immunology
Jing-Mei Lu, Xiang Xu, Fumie Aosai, Ming-Yue Zhang, Lian-Xun Piao
Summary: This study found that arctiin can improve allergic acute liver injury caused by T.g.HSP70 by inhibiting TLR4 signaling and reducing the production of inflammatory mediators.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2024)
Article
Immunology
Minxuan Xu, Fang Shi, Yongshen Gao, Shumei Han, Chensuo Huang, Qinsheng Hou, Xiaoweng Wen, Bengshi Wang, Zhenyu Zhu, Lei Zou, Mingxin Xiong, Wei Dong, Jun Tan
Summary: There is a growing body of research highlighting the involvement of metabolic imbalance and the inflammatory response in the advancement of colitis. This study recognizes arabinose as a significant protector of the intestinal mucosal barrier, reducing damage to the intestines. In addition, lower levels of arabinose in the bloodstream are associated with a higher severity of inflammatory bowel disease and colorectal cancer.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2024)
Article
Immunology
Yueqing Han, Haoxin Song, Yanshan Li, Rongxin Li, Ling Chen, Bo Gao, Yijun Chen, Shuzhen Wang
Summary: The combination of tetracycline antibiotics, demeclocycline (D), chlortetracycline (C), and minocycline (M), showed therapeutic potential against liver fibrosis by inhibiting the activation of hepatic stellate cells and the MAPK signaling. This study suggests that tetracyclines may be repurposed for the treatment of liver fibrosis.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2024)
Article
Immunology
Yu Li, Hailing Liu, Danwen Zhao, Danjie Zhang
Summary: Chronic stress can lead to lung injury, with the spleen playing a crucial role. This study found that the spleen contributes to chronic restraint stress-induced lung injury, and splenic CD11b+ cells may be an important factor in this process.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2024)
Article
Immunology
Yingqian Mi, Mengyan Tang, Qiong Wu, Yinan Wang, Qihui Liu, Pei Zhu, Xiaoyang Xue, Yuntong Liu, Xinyu Chai, Yuyang Hou, Dongmei Yan
Summary: BCG therapy can induce macrophage polarization to the M1 type, and NMAAP1 plays a crucial role in this process by regulating glycolysis and HIF-1α expression. This promotes the antitumor effect of macrophages.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2024)
Article
Immunology
Xiaosheng Liu, Tingxia Lv, Xiuxia Li, Jing Xue, Ling Lin, Lianfeng Lu, Xiaodi Li, Yang Yang, Yuanni Wu, Qiang Wei, Wei Cao, Taisheng Li
Summary: LLDT-8 exhibits notable efficacy in alleviating immune activation in both an in vivo animal model and in vitro human cell experiments, suggesting its potential as a drug for managing systemic immune activation associated with SIV/HIV infection.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2024)
Article
Immunology
Honghong Yu, Qi Li, Huimin Zhu, Chang Liu, Weiwei Chen, Lingyun Sun
Summary: The activation of the inflammasome plays a critical role in the pathogenesis of systemic lupus erythematosus (SLE), and mesenchymal stem cells (MSC) have been shown to alleviate SLE by suppressing inflammasome activation. This study found that the NLRP3 inflammasome was activated in macrophages from SLE patients and mice, and its activation correlated with disease activity. After MSC transplantation, the severity of SLE was reduced, and NLRP3 inflammasome activation was inhibited. These findings suggest that MSC suppress inflammasome activation and provide a potential therapeutic target for SLE.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2024)
Article
Immunology
Wei Zhou, Dan Zeng, Shunan Liu, Yunxia Huang, Fenglin Lv, Weikang Zhou
Summary: This study found that inhibiting HDAC3 can protect the skin from atopic dermatitis by activating the Nrf2 transcription to upregulate Nrf2/HO-1 signaling pathway activity.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2024)